Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Eur Psychiatry ; 46: 1-15, 2017 10.
Article in English | MEDLINE | ID: mdl-28992530

ABSTRACT

BACKGROUND: Chronic hypertension has been associated with an increased risk of cognitive decline. Although a link between hypertension and cognitive decline has been established, there is less evidence supported by systematic reviews. The main aim was to compare different antihypertensive drug groups in relation to their effect on cognition in older patients without established dementia using a systematic review. METHOD: A systematic search in Medline and Embase through to January 2017 was used to identify randomized controlled clinical trials (RCTs) studying the impact of different antihypertensives on cognition in older patients without dementia. Angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACE-Is), beta-blockers (BBs), diuretics, and calcium channel blockers (CCBs) were included in this review. RESULTS: The systematic search identified 358 studies. The full text of 31 RCTs was reviewed and a total of 15 RCTs were included in the review. Most studies reported an improvement in episodic memory in patients treated with ARBs versus placebo or other types of antihypertensive drugs. No study showed an improvement in cognition in patients who received diuretics, BBs, or CCBs. Heterogeneity was high in most trials (predominantly in the blinding of participants and investigators). CONCLUSION: This review suggests that ARBs can improve cognitive functions in the elderly, especially episodic memory. ACE-Is, diuretics, BBs and CCBs did not seem to improve cognitive function in the elderly but were similarly effective in blood pressure lowering as ARBs.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Antihypertensive Agents/classification , Antihypertensive Agents/pharmacology , Cognition/drug effects , Cognition/physiology , Adrenergic beta-Antagonists/pharmacology , Aged , Angiotensin Receptor Antagonists/pharmacology , Antihypertensive Agents/chemistry , Blood Pressure/drug effects , Calcium Channel Blockers/pharmacology , Dementia/complications , Diuretics/pharmacology , Humans , Hypertension/complications , Hypertension/drug therapy , Hypertension/physiopathology , Middle Aged
2.
Acta Psychiatr Scand ; 109(2): 140-6, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14725596

ABSTRACT

OBJECTIVE: To investigate dopamine transporter binding in Gilles de la Tourette syndrome (GTS) with SPECT and [123I]FP-CIT. METHOD: Ten neuroleptic naïve/free patients with GTS, and 10 age- and gender-matched normal volunteers were studied. Subjects were clinically evaluated. GTS severity and affective symptoms were measured and the presence of GTS-related behaviours were recorded. RESULTS: The GTS group showed significantly higher binding in both caudate and putamen nuclei than the controls. No associations were found between striatal binding ratios and measures of affect or GTS-related behaviours. CONCLUSION: Patients with GTS show higher striatal binding of FP-CIT to the striatum in comparison with age- and gender-matched control subjects, indicating that dopamine transporter abnormalities are involved in the pathophysiology of GTS. These abnormalities appear to be distributed across both caudate and putamen.


Subject(s)
Dopamine/metabolism , Membrane Glycoproteins , Membrane Transport Proteins/metabolism , Nerve Tissue Proteins/metabolism , Radiopharmaceuticals , Tourette Syndrome/metabolism , Adolescent , Adult , Corpus Striatum/diagnostic imaging , Dopamine Plasma Membrane Transport Proteins , Female , Humans , Iodine Radioisotopes , Male , Middle Aged , Putamen/diagnostic imaging , Tomography, Emission-Computed, Single-Photon , Tourette Syndrome/diagnostic imaging , Tropanes
3.
J Neurol Neurosurg Psychiatry ; 72(1): 12-21, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11784818

ABSTRACT

This review aims to relate recent findings describing the role and neural connectivity of the basal ganglia to the clinical neuropsychiatry of basal ganglia movement disorders and to the role of basal ganglia disturbances in "psychiatric"' states. Articles relating to the relevant topics were initially collected through MEDLINE and papers relating to the clinical conditions discussed were also reviewed. The anatomy and connections of the basal ganglia indicate that these structures are important links between parts of the brain that have classically been considered to be related to emotional functioning and brain regions previously considered to have largely motor functions. The basal ganglia have a role in the development and integration of psychomotor behaviours, involving motor functions, memory and attentional mechanisms, and reward processes.


Subject(s)
Basal Ganglia Diseases/physiopathology , Basal Ganglia/physiopathology , Mental Disorders/physiopathology , Movement Disorders/physiopathology , Basal Ganglia Diseases/diagnosis , Basal Ganglia Diseases/psychology , Humans , Mental Disorders/diagnosis , Mental Disorders/psychology , Movement Disorders/diagnosis , Movement Disorders/psychology , Neural Pathways/physiopathology
4.
Rev Neurol ; 30(12): 1181-7, 2000.
Article in Spanish | MEDLINE | ID: mdl-10935248

ABSTRACT

INTRODUCTION: At the present time there is considerable controversy over the course to follow in attention to patients with psychogeriatric disorders. Rapid diagnosis and maintaining the patients in their homes are the basic objectives of the policy of sharing responsibility among those involved. DEVELOPMENT: We review the bibliography and suggest a form of attention based on experience acquired in the dementia evaluation unit of the Programme Vida als Anys of the Generalitat de Catalunya. The model described is based on making the diagnosis in the patient's home, giving support to the family and integrating the patient into a follow-up unit, with a person responsible for evaluating and resolving the needs of both patient and family as they arise. In order to carry out this programme, the attention must be given by multidiscliplinary units with the necessary resources.


Subject(s)
Dementia/rehabilitation , Health Services for the Aged/organization & administration , Aged , Ambulatory Care , Dementia/diagnosis , Humans , Psychotherapy , Residential Treatment , Social Support , Spain
5.
Schizophr Bull ; 26(2): 479-93, 2000.
Article in English | MEDLINE | ID: mdl-10885645

ABSTRACT

Simple schizophrenia is widely considered to be a controversial or even discredited entity. However, cases showing typical clinical features continue to be identified in surveys of schizophrenia patients. This article reports on nine patients who met proposed diagnostic criteria for simple schizophrenia. The patients all showed the classical features of social and occupational decline, as well as negative symptoms in the absence of clear-cut positive symptoms. A range of other symptoms, which were either nonspecific or fell short of psychotic phenomena, was also seen. Neuropsychological testing revealed evidence of general intellectual impairment plus deficits in executive function and memory. Computed tomography scans were normal or showed only minor abnormalities. All patients, however, showed abnormalities on single photon emission computerized tomography (SPECT), mainly affecting frontal and temporal regions. It is concluded that cases conforming to the original descriptions of simple schizophrenia continue to be seen and are still best understood as representing a form of schizophrenia.


Subject(s)
Cognition Disorders/psychology , Frontal Lobe/pathology , Schizophrenia/pathology , Schizophrenic Psychology , Temporal Lobe/pathology , Adult , Female , Humans , Male , Memory , Mental Processes , Middle Aged , Tomography, Emission-Computed, Single-Photon , Tomography, X-Ray Computed
6.
Rev. neurol. (Ed. impr.) ; 30(12): 1181-1187, 16 jun., 2000.
Article in Es | IBECS | ID: ibc-20525

ABSTRACT

Introducción. Actualmente, existe una gran controversia sobre la política sanitaria a seguir en la asistencia de pacientes con trastornos psicogeriátricos. El diagnóstico rápido y la contención de los pacientes en el domicilio son los objetivos fundamentales dentro de una política de responsabilidad compartida entre diversos estamentos. Desarrollo. Se lleva a cabo una revisión de la bibliografía y se lanza una propuesta asistencial basada en la experiencia acumulada en la unidad de valoración de las demencias del Programa Vida als Anys de la Generalitat de Catalunya. El modelo expuesto se basa en la realización del diagnóstico a domicilio, apoyo a la familia e integración del paciente dentro de una unidad de seguimiento, con un responsable que valorará y dará soluciones a las necesidades puntuales del paciente y la familia a lo largo de la evolución de la enfermedad. Para que el programa pueda realizarse es preciso que la asistencia sea realizada por unidades multidisciplinarias y se disponga de los medios de soporte necesarios (AU)


Subject(s)
Aged , Humans , Spain , Social Support , Residential Treatment , Psychotherapy , Dementia , Ambulatory Care , Health Services for the Aged
7.
Article in English | MEDLINE | ID: mdl-10223261

ABSTRACT

OBJECTIVE: To examine the role of structural (magnetic resonance imaging [MRI]) and functional (single photon emission computed tomography [SPECT]) imaging and neuropsychologic evaluation in the early diagnosis of frontal variant frontotemporal dementia (fvFTD). BACKGROUND: Current criteria for FTD stress the need for neuropsychologic and functional neuroimaging abnormalities, yet caregivers report lengthy histories of behavioral change. It is not known when, in the course of the disease, these investigations become abnormal, because few longitudinal studies have been reported. METHOD: Longitudinal study of two patients with serial neuropsychologic evaluation and MRI and HMPAO-SPECT scanning. RESULTS: Both patients, men aged 49 and 50, had major changes in personality, behavior, and social conduct that progressed over 5 to 6 years in a way that conformed to the clinical picture of fvFTD. There was remarkably little abnormality on neuropsychologic testing, and MRI and HMPAO-SPECT findings initially were normal. Over time, however, abnormalities on SPECT, frontal atrophy on MRI, or a neuropsychologic profile more typical of fvFTD developed in both patients. CONCLUSIONS: Standard neuropsychologic tests and conventional brain imaging techniques (MRI and SPECT) may not be sensitive to the early changes in fvFTD that occur in the ventromedial frontal cortex, and better methods of accurate early detection are required. These findings are relevant to the diagnostic criteria for FTD.


Subject(s)
Dementia/classification , Dementia/diagnosis , Frontal Lobe , Temporal Lobe , Atrophy , Chronic Disease , Cognition Disorders/diagnosis , Cognition Disorders/etiology , Dementia/complications , Disease Progression , Frontal Lobe/diagnostic imaging , Frontal Lobe/pathology , Humans , Irritable Mood , Longitudinal Studies , Magnetic Resonance Imaging , Male , Memory Disorders/diagnosis , Memory Disorders/etiology , Middle Aged , Neuropsychological Tests , Personality Disorders/complications , Sensitivity and Specificity , Social Behavior Disorders/complications , Technetium Tc 99m Exametazime , Temporal Lobe/diagnostic imaging , Temporal Lobe/pathology , Tomography, Emission-Computed, Single-Photon
8.
Article in English | MEDLINE | ID: mdl-10082333

ABSTRACT

OBJECTIVE: The objective of this study was to determine whether the pathophysiological changes associated with Parkinson's disease (PD) lead to an increased vulnerability to react to negative emotional stimuli and hence to depression. It is hypothesized that nondepressed PD patients will demonstrate, associated with particular PD and/or cognitive variables, vulnerability to the interfering effects of negative words on the Emotional (sad) Stroop task (EST). BACKGROUND: Depression has been reported to occur frequently in PD, but there is controversy regarding its pathophysiology: psychosocial factors versus neurobiologic ones. METHOD: Thirty nondepressed/ nondemented patients with idiopathic PD attending a specialist movement disorders clinic were assessed from their emotional state (Beck's Depression Inventory [BDI], and Hospital Anxiety and Depression Scale) and from their cognitive state (Mini-Mental State Examination, Stroop tasks [including the EST], Modified Card Sorting Test, Word Fluency tasks, Digit Span, and Trail Making tests). In addition, information was gathered on PD-related variables such as severity (Hoehn and Yahr scale), duration of the disease, and type of motor response to dopaminergic drugs. The sample was split into two groups according to the median BDI score to allow for comparisons. One-way ANOVA techniques were used to look for significant differences between variables in the two groups. Bivariate correlations were used to look for significant relationships between variables in each group. RESULTS: The two groups only differed in parameters measuring emotional state. Only the subjects with higher BDI scores showed significant correlations between EST performance and cognitive and PD-related variables. CONCLUSIONS: Those PD patients with more severe forms of illness and a greater level of prefrontal cognitive dysfunction are more vulnerable to the distracting effects of external negative stimuli. According to the cognitive model of depression, this may ultimately lead to the development of clinical depression.


Subject(s)
Affect , Parkinson Disease/physiopathology , Parkinson Disease/psychology , Prefrontal Cortex/physiopathology , Psychological Tests , Vocabulary , Adult , Aged , Aged, 80 and over , Depressive Disorder/diagnosis , Depressive Disorder/etiology , Female , Humans , Male , Middle Aged , Parkinson Disease/diagnosis , Reproducibility of Results , Severity of Illness Index
9.
Rev Neurol ; 26(154): 1054-60, 1998 Jun.
Article in Spanish | MEDLINE | ID: mdl-9658492

ABSTRACT

OBJECTIVE: To review the drugs commercially available at present and in the near future in relation to the evolution of Alzheimer disease, bearing in mind the possible psychiatric disorders which may be associated with the disease. DEVELOPMENT: The therapeutic approach is planned according to the different phases of the disease. In the preclinical phase, anti-inflammatory drugs and estrogens in post-menopausal women have been effective. In the initial phase current recognition therapy is directed basically towards correcting the break-down of acetylcholine (tacrine, donepezil, SB202026, SDZ ENA 713). For depressive symptoms serotonin levels are corrected using selective inhibitors of serotonin uptake. CONCLUSIONS: Drug treatment should be considered with the association of drugs which activate the malfunctioning circuits and/or pathways. It would also be useful to design clinical studies using pharmacological combinations of cholinergic agonists, estrogens, anti-inflammatory drugs, seligiline and/or new anti-cholinesterase drugs amongst others.


Subject(s)
Alzheimer Disease/drug therapy , Nootropic Agents/therapeutic use , Acetylcholine/agonists , Acetylcholine/physiology , Aged , Aggression/drug effects , Alzheimer Disease/metabolism , Alzheimer Disease/psychology , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Anxiety/drug therapy , Anxiety/etiology , Brain Chemistry , Depressive Disorder, Major/drug therapy , Depressive Disorder, Major/etiology , Disease Progression , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Neurotransmitter Agents/agonists , Neurotransmitter Agents/physiology , Psychotic Disorders , Stereotyped Behavior/drug effects , Terminal Care
SELECTION OF CITATIONS
SEARCH DETAIL
...